Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Study Summary
This trial is comparing how well a new imaging agent binds in the brains of people with and without alcohol use disorders.
Eligible Conditions
- Alcoholism
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
[C-11]NOP-1A VT
Trial Design
2Treatment groups
Experimental Treatment
Group I: ControlsExperimental Treatment2 Interventions
[C-11]NOP-1A PET Scan
Group II: Alcohol use disordersExperimental Treatment2 Interventions
[C-11]NOP-1A PET Scan
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
[C-11]
2016
Completed Early Phase 1
~150
NOP-1A
2016
Completed Early Phase 1
~110
Find a Location
Who is running the clinical trial?
Rajesh NarendranLead Sponsor
3 Previous Clinical Trials
121 Total Patients Enrolled
1 Trials studying Alcoholism
11 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
799 Previous Clinical Trials
1,362,457 Total Patients Enrolled
422 Trials studying Alcoholism
985,154 Patients Enrolled for Alcoholism
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger